Reports Q2 revenue $798,000, consensus $1.04M. “Our commercial strategy continued to drive results throughout the quarter with our total number of customers increasing by over 60%,” said Steve Lisi, chairman and CEO of Beyond Air (XAIR). “We believe this is just the beginning of a pivotal year for our Company as we leverage our expanding network of reference customers that have implemented LungFit PH in their hospitals. We have a strong foundation of customer success stories that speak to the cost savings, workflow improvements and additional value our technology delivers in a real-world setting, compared to traditional cylinder-based systems. In addition, since joining our team four months ago, our new Chief Commercial Officer, David Webster, has won key partners to rapidly accelerate our topline growth, including TrillaMed, Healthcare Links and Business Asia Consultants, among others, resetting our commercial strategy and reorganizing our sales, marketing and support teams.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on XAIR:
- Beyond Air presents preclinical data on LV UNO
- Is XAIR a Buy, Before Earnings?
- Beyond Air files to sell 81.7M shares of common stock for holders
- Beyond Air announces strategic partnership with Healthcare Links
- Costco reports Q4 earnings beat, Cassava to settle SEC charges: Morning Buzz
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
